The Nigeria Centre for Disease Control (NCDC) an agency at the centre of the fight against the COVID-19 pandemic in Nigeria has said it expended the sum of N43, 250,000 for the establishment Molecular Laboratory Testing Centre in Adamawa State, northeast Nigeria.
This intervention was designed to help in the containment of COVID-19 in Nigerian and prevents its spread and to ensure health safety of the citizens. This government had argued at the federal level on the need for testing centre across the 774 Local Government Areas of the federation, but said lack of funds deters it from carrying out the project as expected.
This project no doubt has the NCDC, the Nigerian ministry of health, the Adamawa state ministry of health and the officials of the presidential task force as core actors who have played different roles.
The NCDC awarded the project to M/S Malina pharmaceutical Limited. However, checks by WAR shows no link to M/S Malina pharmaceutical Limited.
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform